Browsing by Author von Deimling, Andreas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2011Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cellsSpeidel, Daniel; Barth, S; Breitling, R; Cinatl, J; Cinatl, Jr; Doerr, H W; Fehse, B; Löschmann, N; MacK, E; Michaelis, M; Rödel, F; Rothweiler, F; Stiewe, T; Van Rikxoort, M; Voges, Y; von Deimling, Andreas; Weber, Kristoffer; Children's Hospital Westmead: Childrens Medical Research InsAdaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells, Cell Death and Disease, vol.2, 12, 2011,pp e243 - 1-e243 - 8
2011An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptorGuillemin, Gilles; Jestaedt, Leonie; Jugold, Manfred; Lehmann, Irina; Litzenburger, Ulrike; Lutz, Christian; Miller, Christine; Opitz, Christiane; Ott, Martina; Platten, Michael; Radlwimmer, Bernhard; Sahm, Felix; Schrenk, Dieter; Schumaker, Theresa; Tritschler, Isabel; Trump, Saskia; von Deimling, Andreas; Weller, Michael; Wick, Wolfgang; School of Medical Sciences: School of Medical SciencesAn endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor, Nature: international weekly journal of science, vol.478, 7368, 2011,pp 197-203
2012Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agentsSpeidel, Daniel; Agha, B; Barth, S; Breitling, R; Cinatl, Jr; Doerr, H W; Loschmann, N; Michaelis, M; Rodel, F; Rothweiler, F; Voges, Y; von Deimling, Andreas; Children's Hospital Westmead: Childrens Medical Research InsHuman neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents, Cell Death and Disease, vol.3, 4, 2012,pp 1-8
2013Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in MelanomaKefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Thompson, John; Wilmott, James; Capper, D; Preusser, Matthias; von Deimling, Andreas; Zhang, Yuxiao; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryImmunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma, The American Journal of Surgical Pathology, vol.37, 1, 2013,pp 61-65
2010Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer SurvivalHenson, Jeremy; McDonald, Kerrie; McDonnell, Julie; Reddel, Roger; Robinson, Bruce; Biggs, Michael T.; Cook, Raymond J.; Hegi, MoniKA; Little, Nicholas S.; Muntoni, Alessandra; Royds, Janice; von Deimling, Andreas; Wheeler, Helen; Children's Hospital Westmead: Childrens Medical Research Ins; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Children's Hospital Westmead: Childrens Medical Research Ins; Northern Clinical School: MedicinePresence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival, Journal of Neuropathology and Experimental Neurology, vol.69, 7,pp 729-736
2012Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinomaClifton-Bligh, Roderick; Delbridge, Leigh; Gill, Anthony; Learoyd, Diana; Robinson, Bruce; Bullock, Martyn; Capper, D; Chou, Angela; Clarkson, A; Dodds, T; O'Neil, C; Sidhu, Stan; Sywak, M; Toon, C; von Deimling, Andreas; Northern Clinical School: Medicine; Northern Clinical School: Surgery; Northern Clinical School: Pathology; Northern Clinical School: Medicine; Northern Clinical School: MedicineUtilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma, Endocrine-Related Cancer, vol.19, 6, 2012,pp 779-784